Elanco Animal Health (United States) is listed on the Nasdaq and has a market capitalization of $13.21 billion, with shareholders equity totaling $6.63 billion.
The company employs approximately 9.400 people and operates in the Other sector, within the Other industry.
Over the past 12 months, Elanco Animal Health reported $5.15 billion in revenue, generating net income of $-147.00 million.
Key financial metrics include a P/E ratio of -89.84, a price-to-book (P/B) ratio of 1.99, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ELAN.